Given that they increase natriuresis, reduce cardiac load, improve renal function, and have excellent performance in treatment of chronic HF, SGLT2 inhibitors are hypothesized to be beneficial in acute HF as well. Here, SLC5A2 is linked to hydrops fetalis.